Based in the United Kingdom, Adaptimmune is a startup.
Adaptimmune develops engineered T-cell therapies designed to treat cancer by arming immune cells to recognize and destroy cancer cells.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.